Estimaciones de analistas de Wall Street para PAVmed Inc. (PAVM): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.63 | ||
| 2026-08-14 | $-0.87 | $-0.47 | -85.1% |
| 2026-05-15 | $-4.42 | $-0.69 | -540.6% |
| 2026-03-26 | $-2.05 | $-4.50 | +54.4% |
| 2025-11-13 | $-8.70 | $-5.10 | -70.6% |
| 2025-08-14 | $-22.20 | $-3.90 | -469.2% |
| 2025-05-14 | $-2.10 | $-8.71 | +75.9% |
| 2025-03-24 | $-1.80 | $-3.30 | +45.5% |
Ratios de valoración
| Precio / Valor contable | 0.70 |
| EV / EBITDA | -2.65 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | $500000 | $377000 | $2.5M | $3.0M | $71000 |
| Coste de Ventas | $3793 | $7110 | $9790 | $14226 | 0 | $585000 | $3.6M | $6.4M | $6.0M | $323000 |
| Beneficio Bruto | -$3793 | -$7110 | -$9790 | -$14226 | 0 | -$85000 | -$3.2M | -$4.0M | -$3.0M | -$252000 |
| I+D | $1.7M | $2.6M | $4.3M | $6.6M | $11.0M | $19.8M | $25.3M | $14.3M | $5.9M | $4.49B |
| Generales y Administrativos | $3.9M | $5.4M | $6.3M | $7.7M | $12.4M | $34.3M | $60.7M | $48.5M | $36.2M | $17.17B |
| Gastos Operativos | $5.7M | $8.0M | $10.6M | $14.3M | $23.4M | $54.3M | $87.8M | $64.8M | $41.4M | $21.6M |
| Beneficio Operativo | -$5.7M | -$8.0M | -$10.6M | -$14.3M | -$23.4M | -$54.4M | -$91.1M | -$68.8M | -$44.5M | -$21.8M |
| EBITDA | -$5.6M | -$11.2M | -$12.1M | -$16.7M | -$23.3M | -$55.9M | -$99.5M | -$75.7M | $29.7M | -$2.3M |
| Gastos por Intereses | 0 | $724684 | $2.4M | $32667 | $53000 | 0 | $1.3M | $589000 | $45000 | $21000 |
| Beneficio Antes de Impuestos | -$5.7M | -$9.5M | -$18.2M | -$17.3M | -$35.9M | -$56.1M | -$103.2M | -$79.3M | $28.4M | -$2.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.7M | -$9.5M | -$18.0M | -$15.9M | -$34.3M | -$50.3M | -$89.0M | -$64.2M | $39.8M | $401000 |
| BPA | $-198.00 | $-346.50 | $-378.78 | $-249.27 | $-327.91 | $-293.92 | $-450.95 | $-274.92 | $99.15 | $-5.63 |
| BPA Diluido | $-198.00 | $-346.50 | $-378.78 | $-249.27 | $-327.91 | $-293.92 | $-450.95 | $-274.92 | $14.88 | $-5.63 |
| Acciones en Circulación (Diluidas) | $28827 | $29991 | $49503 | $67105 | $105405 | $172257 | $197947 | $241052 | $2.2M | $670466 |
Precio
| Precio | $3.92 |
| Capitalización | $25M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADVB · APVO · BMRA · BNR · DHAI · HSCS · IINN
Explorar sector: Healthcare · Medical - Devices
Más secciones de PAVM: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones